Related Experiment Video
Updated: Jun 18, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Common Mediterranean fever gene mutations in the Azeri Turkish population of Iran
Abstract:
Familial Mediterranean fever (FMF) is an autosomal recessive disorder primarily affecting the Mediterranean populations. It is characterized by recurrent attacks of fever and inflammation of serosal membranes and gradual development of nephropathic amyloidosis. More than 70 disease-associated mutations have been identified in the Mediterranean fever gene (MEFV) responsible for FMF. The aim of this study was to determine the mutation carrier rate in the Iranian Azeri Turkish population. A cohort of 200 unrelated healthy individuals was screened for the five most common MEFV mutations (M694V, V726A, M680I, M694I, and E148Q) using the amplification refractory mutation system for the first four and by polymerase chain reaction-restriction-digestion testing for E148Q. Genotyping revealed that the carrier rate in the Azeri Turkish population was 25.5%, with E148Q being the most common mutation (11.5%) followed by V726A (1.75%). The remaining common mutations were not found in this cohort. Our data indicate that the FMF carrier rate and E148Q mutation frequency are high in the Iranian Azeri Turkish population.
Insights
Familial Mediterranean fever (FMF) carrier rates are high in the Iranian Azeri Turkish population, with the E148Q mutation being the most frequent. This study screened 200 healthy individuals for common MEFV gene mutations.
Area of Science:
- Genetics
- Population Health
- Molecular Biology
Background:
- Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder.
- Characterized by recurrent fever, serosal inflammation, and risk of nephropathic amyloidosis.
- Over 70 mutations in the Mediterranean fever gene (MEFV) are linked to FMF.
Discussion:
- This study investigated the carrier rate of five common MEFV mutations in 200 healthy Iranian Azeri Turks.
- Genotyping utilized amplification refractory mutation system (ARMS) and polymerase chain reaction-restriction digestion.
- Identified a high FMF carrier rate of 25.5% in this population.
Key Insights:
- The E148Q mutation was the most prevalent, found in 11.5% of individuals.
- V726A mutation was observed at a frequency of 1.75%.
- Other common MEFV mutations were not detected in the screened cohort.
Outlook:
- High carrier frequency of FMF and E148Q mutation in Iranian Azeri Turks warrants further investigation.
- Potential implications for genetic counseling and FMF screening programs in the region.
- Further research could explore the clinical significance of these mutations in the population.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Hepatitis
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Mutations in Microorganisms